Patient Exclusion Analysis Coming From FDA; Changes In Trial Recruitment Could Follow
This article was originally published in The Pink Sheet Daily
Executive Summary
Subjects with psychiatric conditions are often excluded from trials, an agency study finds, which “doesn’t seem a good thing” to Bob Temple.